BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 32495220)

  • 41. The predictive value of hematological inflammatory markers for acute kidney injury and mortality in adults with hemophagocytic Lymphohistiocytosis: A retrospective analysis of 585 patients.
    Chen X; Wang S; Yang J; Wang X; Yang L; Zhou J
    Int Immunopharmacol; 2023 Sep; 122():110564. PubMed ID: 37451019
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Causes, clinical symptoms, and outcomes of infectious diseases associated with hemophagocytic lymphohistiocytosis in Taiwanese adults.
    Tseng YT; Sheng WH; Lin BH; Lin CW; Wang JT; Chen YC; Chang SC
    J Microbiol Immunol Infect; 2011 Jun; 44(3):191-7. PubMed ID: 21524613
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical features of adult patients with secondary hemophagocytic lymphohistiocytosis from causes other than lymphoma: an analysis of treatment outcome and prognostic factors.
    Park HS; Kim DY; Lee JH; Lee JH; Kim SD; Park YH; Lee JS; Kim BY; Jeon M; Kang YA; Lee YS; Seol M; Lee YJ; Lim YS; Jang S; Park CJ; Chi HS; Lee KH
    Ann Hematol; 2012 Jun; 91(6):897-904. PubMed ID: 22147006
    [TBL] [Abstract][Full Text] [Related]  

  • 44. PEG-aspargase and DEP regimen combination therapy for refractory Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.
    Wang J; Wang Y; Wu L; Zhang J; Lai W; Wang Z
    J Hematol Oncol; 2016 Sep; 9(1):84. PubMed ID: 27613189
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Malignancy-associated hemophagocytic lymphohistiocytosis in pediatric cases: a multicenter study from Turkey.
    Celkan T; Berrak S; Kazanci E; Ozyürek E; Unal S; Uçar C; Yilmaz S; Gürgey A
    Turk J Pediatr; 2009; 51(3):207-13. PubMed ID: 19817262
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical features and outcomes of patients with hemophagocytic lymphohistiocytosis at onset of systemic autoinflammatory disorder and compare with Epstein-Barr virus (EBV)-related hemophagocytic lymphohistiocytosis.
    Zhao Y; Li Z; Zhang L; Lian H; Ma H; Wang D; Zhao X; Zhang Q; Wang T; Zhang R
    Medicine (Baltimore); 2020 Jan; 99(1):e18503. PubMed ID: 31895784
    [TBL] [Abstract][Full Text] [Related]  

  • 47. HLA-mismatched GPBSC infusion therapy in refractory Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis: an observational study from a single center.
    Song Y; Wang J; Wang Y; Wang Z
    Stem Cell Res Ther; 2020 Jul; 11(1):265. PubMed ID: 32611452
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Characteristics and prognostic value of pleural effusion in secondary hemophagocytic lymphohistiocytosis.
    Cheng W; Gao X; Yin G; Huang J; Man C; Qiu H
    Int J Hematol; 2022 Jul; 116(1):102-109. PubMed ID: 35338447
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Epstein-Barr Virus-Related Hemophagocytic Lymphohistiocytosis with Central Nervous System Symptoms.
    Sakaguchi M; Nagata Y; Terasaki Y; Takeyoshi A; Yasuda S; Honma S; Kinoshita R; Marumo A; Asayama T; Yui S; Wakita S; Okamoto M; Kajimoto Y; Inokuchi K; Yamaguchi H
    J Nippon Med Sch; 2023 Mar; 90(1):126-135. PubMed ID: 36436914
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Elevated Interleukin-10 Levels Are Associated with Low Platelet Count and Poor Prognosis in 90 Adult Patients with Hemophagocytic Lymphohistiocytosis.
    Hao L; Ren J; Zhu Y; Ma Y; Pan J; Yang L
    Int Arch Allergy Immunol; 2023; 184(4):400-408. PubMed ID: 36634629
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pediatric hemophagocytic lymphohistiocytosis: A rarely diagnosed entity in a developing country.
    Cleves D; Lotero V; Medina D; Perez PM; Patiño JA; Torres-Canchala L; Olaya M
    BMC Pediatr; 2021 Sep; 21(1):411. PubMed ID: 34537050
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hematopoietic stem cell transplantation for familial hemophagocytic lymphohistiocytosis and Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in Japan.
    Ohga S; Kudo K; Ishii E; Honjo S; Morimoto A; Osugi Y; Sawada A; Inoue M; Tabuchi K; Suzuki N; Ishida Y; Imashuku S; Kato S; Hara T
    Pediatr Blood Cancer; 2010 Feb; 54(2):299-306. PubMed ID: 19827139
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Case of haemophagocytic lymphohistiocytosis following Epstein-Barr virus infection.
    Kraskovsky V; Harhay J; Mador MJ
    BMJ Case Rep; 2021 Mar; 14(3):. PubMed ID: 33789863
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fatal hemophagocytic syndrome in a patient with a previously well-controlled asymptomatic HIV infection after EBV reactivation.
    Thoden J; Rieg S; Venhoff N; Wennekes V; Schmitt-Graeff A; Wagner D; Kern WV
    J Infect; 2012 Jan; 64(1):110-2. PubMed ID: 21888928
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Flow Cytometric Analysis of T Cells in Hemophagocytic Lymphohistiocytosis.
    Park MS; Yoo IY; Kim HJ; Kim SH; Kim SJ; Cho D
    Ann Lab Med; 2019 Sep; 39(5):430-437. PubMed ID: 31037861
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Monitoring of Epstein-Barr virus-infected cells by flow cytometer permits early diagnosis and evaluation of disease progression in EBV-associated hemophagocytic lymphohistiocytosis].
    Fukuda M; Nishimura R; Araki R; Kuroda R; Mase S; Nakagawa Y; Tone Y; Maeba H; Wada T; Kasahara Y; Yachie A
    Rinsho Ketsueki; 2012 Mar; 53(3):337-41. PubMed ID: 22499051
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Epstein-Barr Virus-Positive Lymphoma-Associated Hemophagocytic Syndrome: A Retrospective, Single-Center Study of 51 Patients.
    Zhao A; Yang J; Li M; Li L; Gan X; Wang J; Li H; Shen K; Yang Y; Niu T
    Front Immunol; 2022; 13():882589. PubMed ID: 35479073
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Acute fibrinous and organizing pneumonia complicated with hemophagocytic lymphohistiocytosis caused by chronic active Epstein-Barr virus infection: a case report.
    Wu X; Wang K; Gao Y; Cai Y; Wang W; Zhong D; Zhan Q
    BMC Infect Dis; 2021 Dec; 21(1):1207. PubMed ID: 34863102
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Rescue of HLH with T and B Lymphocyte Involvement Due to Epstein-Barr Virus by PD-1 Inhibitor/Ruxolitinib and Rituximab Combination Regimens: A Case Report.
    Zhu M; Zhang J; Shi Q; Sun X; Wang H; Sun M; Liu Y
    Iran J Immunol; 2023 Dec; 20(4):466-472. PubMed ID: 37873944
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prognostic scoring system for pediatric Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis based on baseline characteristics: A multicenter retrospective study.
    Kong Q; Li M; Wang J; Wu L; Zhou D; Yang M; Xu X; Tan Z; Wu X; Wang Z
    Pediatr Blood Cancer; 2024 Feb; 71(2):e30772. PubMed ID: 37974392
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.